Every article we've published on PharmEasy — results, funding rounds, IPO plans and market commentary. Information only, not advice.
PharmEasy’s parent API Holdings wants full control of Akna Medical, its medicine wholesale arm. But instead of paying cash, it’s handing Lightrock ₹347.5 crore worth of new shares. We break down the deal, what a CCPS is, why it could point …
API Holdings could be debt-free within days. That clears the first of two conditions standing between PharmEasy and a reverse merger into Thyrocare — …
PharmEasy’s parent, API Holdings, has been struggling for the last two years with tight liquidity, debt refinancing challenges, and delayed IPO …
Introduction PharmEasy, one of Mumbai’s leading health-tech unicorns, has taken a decisive financial step by raising ₹1,700 crore in a debt roun…
In a major leadership transition at API Holdings, the parent company of digital health unicorn PharmEasy, co-founder and CEO Siddharth Shah has steppe…
Executive Summary All Home, founded by the core team behind PharmEasy, is revolutionizing India's $30B+ interior design industry. The startup, now val…
PharmEasy, one of India's leading digital healthcare platforms, has launched a fresh marketing campaign designed to drive adoption and trust in its di…
Indicative prices, company research and your enquiries — in your pocket. Get price notes on the names you follow and reach our team from anywhere.
